INSULIN-LIKE GROWTH FACTORS IN GROWTH, INVASIVENESS AND MOTILITY OF BRAIN TUMORS
脑肿瘤生长、侵袭性和运动性中的胰岛素样生长因子
基本信息
- 批准号:3751879
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:biological signal transduction cell cycle cell growth regulation cell motility glioblastoma multiforme growth factor receptors human tissue in situ hybridization insulinlike growth factor medulloblastoma neoplasm /cancer invasiveness northern blottings receptor binding tissue /cell culture transport proteins
项目摘要
Primary CNS neoplasms account for 20% of all pediatric malignancies and
are the most common solid tumors in children. Insulin-like growth factor
I and II (IGF-I and IGF-II) have been demonstrated to influence growth,
development and differentiation in numerous peripheral tissues and in
primary cultures of astroglial and neuronal cells from fetal brain. The
endogenous production of IGFs and their binding proteins as well as the
presence of IGF receptors in the brain suggests that these peptides may
regulate proliferation, development and differentiation of brain cells
(1,2). In addition, IGFs have been shown to act by endocrine, autocrine
or paracrine pathways in the growth regulation of several human
malignancies (3-5). We have recently reported that IGF-II is an
autocrine growth factor for human rhabdomyosarcomas, and is an autocrine
and/or paracrine growth factor for neuroblastomas (4-5). Recent studies
have identified the presence of IGF receptors and specific mRNA for IGF-I
and II in some human brain tumors (6,7). Therefore, we hypothesize that
IGFs play an active role in the growth regulation of human brain
malignancies.
We recently reported that IGF-II stimulates cell motility in human
rhabdomyosarcomas (9). Malignant gliomas and medulloblastomas are
characterized by a high degree of local invasiveness. Since tumor
invasion requires active locomotion, we hypothesize that IGFs play a key
role in modulating tumor cell locomotion and, hence, invasion. We
speculate that these functions may be mediated by the type II receptor,
in analogy to what we have shown in rhabdomyosarcoma (9).
Therefore, we will characterize IGFs, IGF receptors, and IGF binding
proteins in human brain tumor cells and analyze their relationship to
tumor growth, motility, and invasion.
原发性CNS肿瘤占所有儿科恶性肿瘤的20%,
是儿童中最常见的实体瘤。 胰岛素样生长因子
I和II(IGF-I和IGF-II)已被证明影响生长,
在许多外周组织中的发育和分化,
胎脑星形胶质细胞和神经元细胞的原代培养物。 的
IGFs及其结合蛋白的内源性产生,以及
大脑中IGF受体的存在表明这些肽可能
调节脑细胞的增殖、发育和分化
(1,2)。 此外,IGFs已被证明是通过内分泌、自分泌
或旁分泌途径在几个人的生长调节
恶性肿瘤(3-5)。 我们最近报道IGF-II是一种
自分泌生长因子的人横纹肌肉瘤,是一种自分泌
和/或用于神经母细胞瘤的旁分泌生长因子(4-5)。 最近的研究
已经鉴定了IGF受体和IGF-I的特异性mRNA的存在
和II在一些人类脑肿瘤中(6,7)。 因此,我们假设
IGFs在人脑的生长调节中起着积极的作用
恶性肿瘤。
我们最近报道了IGF-II刺激人类细胞运动,
横纹肌肉瘤9例。 恶性神经胶质瘤和髓母细胞瘤是
以高度的局部侵袭性为特征。 由于肿瘤
入侵需要主动运动,我们假设IGFs在这一过程中起着关键作用。
在调节肿瘤细胞运动和侵袭中的作用。 我们
推测这些功能可能由II型受体介导,
类似于我们在横纹肌肉瘤中所示(9)。
因此,我们将描述IGF,IGF受体和IGF结合
人类脑肿瘤细胞中的蛋白质,并分析它们与
肿瘤生长、运动和侵袭。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CATERINA MINNITI其他文献
CATERINA MINNITI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CATERINA MINNITI', 18)}}的其他基金
A RANDOMIZED, OPEN-LABEL, MULTI-CENTER PHASE II STUDY TO EVALUATE THE SAFETY
评估安全性的随机、开放标签、多中心 II 期研究
- 批准号:
7608372 - 财政年份:2006
- 资助金额:
-- - 项目类别:
PULMONARY HYPERTENSION AND THE HYPOXIC RESPONSE IN SICKLE CELL DIESEASE:
镰状细胞病的肺动脉高压和缺氧反应:
- 批准号:
7608382 - 财政年份:2006
- 资助金额:
-- - 项目类别:
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL: BABY HUG
儿科羟基脲 III 期临床试验:婴儿拥抱
- 批准号:
7608346 - 财政年份:2006
- 资助金额:
-- - 项目类别:
SILENT CEREBRAL INFARCT MULTI-CENTER CLINICAL TRIAL (SITT)
无症状脑梗塞多中心临床试验 (SITT)
- 批准号:
7199737 - 财政年份:2005
- 资助金额:
-- - 项目类别:
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL: BABY HUG
儿科羟基脲 III 期临床试验:婴儿拥抱
- 批准号:
7376189 - 财政年份:2005
- 资助金额:
-- - 项目类别:
A RANDOMIZED, OPEN-LABEL, MULTI-CENTER PHASE II STUDY TO EVALUATE THE SAFETY
评估安全性的随机、开放标签、多中心 II 期研究
- 批准号:
7376225 - 财政年份:2005
- 资助金额:
-- - 项目类别:
相似海外基金
Investigating ubiquitination-regulated cell cycle events underpinning malaria transmission
研究泛素化调节的细胞周期事件支撑疟疾传播
- 批准号:
MR/Y013174/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Investigating cell cycle vulnerabilities in TP53 mutant cancers
研究 TP53 突变癌症的细胞周期脆弱性
- 批准号:
MR/Y01264X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Conference: FASEB Yeast Chromosome and Cell Cycle Conference 2024
会议:2024 年 FASEB 酵母染色体和细胞周期会议
- 批准号:
2403471 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
MRC TS Award: Regulation of neutrophil functions by cell cycle proteins
MRC TS 奖:细胞周期蛋白调节中性粒细胞功能
- 批准号:
MR/X023087/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fellowship
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication
不完全复制后结构变异形成的细胞周期时间和分子机制
- 批准号:
10656861 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Cell cycle control of cell polarity and fate in epidermal morphogenesis
表皮形态发生中细胞极性和命运的细胞周期控制
- 批准号:
10608036 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Cell cycle-dependent dynein adaptor switching
细胞周期依赖性动力蛋白适配器转换
- 批准号:
23KF0285 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for JSPS Fellows
Regulation of Cell Cycle progression by the nuclear envelope
核膜对细胞周期进程的调节
- 批准号:
10659597 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




